Published in In Vivo on April 19, 1999
Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians. J Diabetes Investig (2012) 0.90
Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma. Mol Med (2011) 0.78
Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients. J Cancer Sci Ther (2014) 0.75
The prognostic influence of body mass index, resting energy expenditure and fasting blood glucose on postoperative patients with esophageal cancer. BMC Gastroenterol (2016) 0.75
Survival of patients with lung cancer and diabetes mellitus. Mol Clin Oncol (2017) 0.75
Molecular evidence for tuberculosis in an ancient Egyptian mummy. Lancet (1997) 1.91
1997 Volvo Award winner in basic science studies. Immunohistologic markers for age-related changes of human lumbar intervertebral discs. Spine (Phila Pa 1976) (1997) 1.75
High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest (1998) 1.71
Ancient Egyptian prosthesis of the big toe. Lancet (2001) 1.18
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia (1999) 1.17
AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol (2000) 1.15
epsilon-Amino-lysine-bound glucose in human tissues obtained at autopsy. Increase in diabetes mellitus. Diabetes (1982) 1.05
Molecular mechanism of diabetic nephropathy. Clin Chim Acta (2000) 1.04
Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia (2002) 1.04
Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes (1998) 1.01
Anthropological and palaeopathological analysis of the human remains from three "Tombs of the Nobles" of the necropolis of Thebes-west, upper Egypt. Anthropol Anz (2000) 0.98
Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res (1996) 0.97
Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats. J Am Soc Nephrol (2000) 0.96
IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise. Diabetologia (2010) 0.95
Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. Am J Respir Cell Mol Biol (2000) 0.90
Malignant tumors in an ancient Egyptian population. Anticancer Res (2000) 0.90
High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol (1996) 0.88
N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress. Atherosclerosis (1999) 0.87
Quantitation of TGF-beta1 mRNA in porcine mesangial cells by comparative kinetic RT/PCR: comparison with ribonuclease protection assay and in situ hybridization. J Clin Lab Anal (2001) 0.87
Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer. Anticancer Res (1998) 0.87
Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells. Diabetologia (2003) 0.86
Simultaneous, quantitative analysis of UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine, UDP-glucose and UDP-galactose in human peripheral blood cells, muscle biopsies and cultured mesangial cells by capillary zone electrophoresis. Electrophoresis (2000) 0.86
Glucose oversupply increases Delta9-desaturase expression and its metabolites in rat skeletal muscle. Diabetologia (2003) 0.85
Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int (1994) 0.83
Activation of the mitogen-activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise. Diabetologia (2010) 0.83
Overexpression of glutamine:fructose-6-phosphate-amidotransferase induces transforming growth factor-beta1 synthesis in NIH-3T3 fibroblasts. FEBS Lett (2001) 0.82
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Acta Neuropathol (2005) 0.82
Prognostic aspects of the loss of epithelial basement membrane components in preinvasive and invasive laryngeal carcinomas. Anticancer Res (1998) 0.81
Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells. Biochim Biophys Acta (1990) 0.79
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. Kidney Int (2001) 0.79
N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies. Acta Neuropathol (2002) 0.79
Prolonged glucose infusion into conscious rats inhibits early steps in insulin signalling and induces translocation of GLUT4 and protein kinase C in skeletal muscle. Diabetologia (2002) 0.78
Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. Anticancer Res (1998) 0.78
High concentrations of low density lipoprotein decrease basement membrane-associated heparan sulfate proteoglycan in cultured endothelial cells. FEBS Lett (1990) 0.78
Upregulation of myo-inositol transport compensates for competitive inhibition by glucose. An explanation for the inositol paradox? Diabetes (1993) 0.77
Selective association of plasma non-esterified fatty acid species with circulating interleukin-8 concentrations in humans. Exp Clin Endocrinol Diabetes (2008) 0.76
Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis. Contrib Nephrol (2001) 0.76
Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia (1992) 0.76
Divergence in distribution and prognostic significance of major basement components in laryngeal carcinomas. Int J Oncol (2001) 0.75
Clinical utility of nonenzymatically glycosylated blood proteins as an index of glucose control. Diabetes Care (1985) 0.75
Glycosaminoglycan prevents hyperglycemia-induced renal TGF-beta 1 gene expression. Nephrol Dial Transplant (1999) 0.75
Alkaline liquid chromatography/electrospray ionization skimmer collision-induced dissociation mass spectrometry for phosphopeptide screening. Rapid Commun Mass Spectrom (2001) 0.75
Differential kinetics of glucose metabolism in porcine retinal and aortic endothelial cells. J Clin Chem Clin Biochem (1990) 0.75
Advances in reverse transcription polymerase chain reaction analysis of cellular mRNA levels of transforming growth factor-beta1 by capillary electrophoresis with laser-induced fluorescence detection. Clin Chem Lab Med (1999) 0.75
In-vitro carboxymethylation of low density lipoprotein alters its metabolism via the high-affinity receptor. Horm Metab Res (1993) 0.75
Localization of extracellular matrix components in congenital nephrotic syndromes. Pediatr Nephrol (1995) 0.75
Analysis of total urinary catecholamines by liquid chromatography: methodology, routine experience and clinical interpretations of results. Clin Chim Acta (1983) 0.75
Defective basement membrane in laryngeal carcinomas with heterogeneous loss of distinct components. Hum Pathol (1998) 0.75